[Nitic oxide and natriuretic peptides].
Nakaki
T
T
Department of Pharmacology, Teikyo University School of Medicine, Tokyo, Japan. nakaki@med.teikyo-u.ac.jp
D000067956:Adenylyl Cyclase Inhibitors; D001241:Aspirin / Q000031:analogs & derivatives; D006152:Cyclic GMP / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D045283:Natriuretic Agents / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D020030:Nitric Oxide Donors; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D005996:Nitroglycerin; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D000068677:Sildenafil Citrate; D013438:Sulfhydryl Compounds; D013450:Sulfones
D000067956:Adenylyl Cyclase Inhibitors; D045283:Natriuretic Agents; D020030:Nitric Oxide Donors; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013438:Sulfhydryl Compounds; D013450:Sulfones; D009569:Nitric Oxide; D000068677:Sildenafil Citrate; D019001:Nitric Oxide Synthase; C102148:nitroaspirin; D005996:Nitroglycerin; D006152:Cyclic GMP; D001241:Aspirin